Pharmacology

Giving a neuromuscular blocking agent early in ARDS may improve survival

According to a study in the New England Journal of Medicine, administering a neuromuscular blocking agent for 48 hours at the onset of severe Adult Respiratory Distress Syndrome (ARDS) improved patient survival at 90 days without worsening muscle weakness. Read more here.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares